Sarepta Therapeutics | Company Profile
11/10/2025
Contact Information
👤
Sarepta Therapeutics
🏢
Sarepta Therapeutics
📍
215 First Street, Cambridge, MA 02142, US
Industry & Market
Primary Industry
research
All Industries
researchbiotechnology
Location
Cambridge, Massachusetts, United States
Public Trading
NASDAQ: SRPT
Company Metrics
👥Total Employees
474
⚙️Engineering
68
💼Sales Team
2
📈Marketing
18
📅Founded
1980
💰Revenue
1.9B
Alexa Ranking#222115
Funding Information
Market Cap
$1.7B
Annual Revenue
$1,901,979,000
Publicly traded company
Headcount Distribution
Total Employees
474
Departments
19
By Department
Department Breakdown
Operations
Engineering
Information Technology
Business Development
Education
Human Resources
Others
Technology Stack
Analytics & Tracking
Google AnalyticsGoogle Tag Manager
Social & Marketing
Facebook Custom AudiencesFacebook Login (Connect)Facebook Widget
Video & Media
Vimeo
Email & Communication
Outlook
Total: 31 technologies
Keywords & Focus Areas
biotechnologylife sciencesbiotechnology: pharmaceutical preparationshealth carebiotechnology researchgenetic medicine manufacturingdisease-specific therapiesclinical trialsbiotech global presencecharcot-marie-tooth diseasebiotech innovation ecosystembiotech manufacturingduchenne muscular dystrophybiotech manufacturing capacityb2bgenetic mutation correctiongene therapy clinical trialsgene editing platformsgenetic disorder treatmentpersonalized medicine+10 more
30 total keywords
Sarepta Therapeutics
Overview
Sarepta Therapeutics is a biotechnology company based in Cambridge, Massachusetts, with a significant research center in Columbus, Ohio. Founded in 1980, the company specializes in developing precision genetic medicines for rare diseases, particularly focusing on Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs).
The company has a portfolio of FDA-approved therapies for DMD that work by restoring the production of dystrophin, a vital muscle protein. Sarepta is also pursuing gene therapy programs for LGMDs and is dedicated to transforming the lives of patients with rare genetic diseases through innovative treatments and rapid innovation to improve patient outcomes.
Basic Information
| Industry | research |
|---|---|
| Founded | 1980 |
| Revenue | 1.9B |
| Headquarters | 215 First Street, Cambridge, MA 02142, United States |
| Languages | English |
| Alexa Ranking | 222115 |
Contact Details
- Phone: +1 617-274-4000
- Website: sarepta.com
- LinkedIn: linkedin.com/company/sarepta-therapeutics
Key Focus Areas & Initiatives
- Biotechnology research and development
- Precision genetic medicine for rare diseases
- Duchenne muscular dystrophy therapies
- Limb-girdle muscular dystrophy gene therapy
- FDA-approved DMD treatments
- Genetic medicine manufacturing
- Clinical trials for neuromuscular disorders
- Gene editing technologies
- Personalized medicine approaches
- Rare disease biotech innovation
- Patient advocacy and support programs
- Global biotech collaborations
- Therapeutic candidates pipeline
- Biotech regulatory strategy
- Commercial manufacturing capability
- RNA-based drug development
Technologies Used
- AI
- Akamai RUM
- Amazon AWS
- Bing Ads
- CSC Corporate Domains
- Circle
- CloudFlare CDN
- CloudFlare Hosting
- DoubleClick Floodlight
- Drupal
- EasyDNS
- Facebook Custom Audiences
- Facebook Login (Connect)
- Facebook Widget
- Formstack
- Google Analytics
- Google Font API
- Google Tag Manager
- Microsoft Office 365
- Mimecast
- Mobile Friendly
- New Relic
- Nginx
- Outlook
- Remote
- Stripe
- Varnish
- Vimeo
- Workday
- Workday Recruit
- reCAPTCHA
Community
